Axon Enterprise, Inc. Stock News

If Axon is right, Tasers for private citizens could be a bigger business than Tasers for law enforcement.

The stun-gun maker quadruples analyst estimates and sees its market opportunity nearly doubling.

If Axon is right, Tasers for private citizens could be a bigger business than Tasers for law enforcement.

The stun-gun maker quadruples analyst estimates and sees its market opportunity nearly doubling.

Craig Hallum upgraded shares of Axon Enterprise (NASDAQ:AXON) from a hold rating to a buy rating in a report released on Tuesday morning, Analyst Ratings Network reports. They currently have $232.00 target price on the biotechnology companys stock. Several other equities analysts have also issued reports on AXON. Zacks Investment Research upgraded Axon Enterprise from []

Axon recently reported its Q3 earnings and is expanding its offerings to consumers and international markets. Read more to see why I think AXON is a Buy.

Axon Enterprise (NASDAQ:AXON) issued its quarterly earnings data on Monday. The biotechnology company reported $1.17 EPS for the quarter, beating the Zacks consensus estimate of $0.26 by $0.91, MarketWatch Earnings reports. The business had revenue of $231.99 million for the quarter, compared to analyst estimates of $201.11 million. Axon Enterprise had a negative return on []

Shares of Arizona-based Axon Enterprise, Inc. (AXON) gained up to 22. The post Axon Enterprise Reports Excellent Q3 Results; Shares Jump 22.5% appeared first on Smarter Analyst .

Axon Enterprise (NASDAQ:AXON) issued its quarterly earnings data on Monday. The biotechnology company reported $1.17 EPS for the quarter, topping the consensus estimate of $0.26 by $0.91, MarketWatch Earnings reports. The firm had revenue of $231.99 million during the quarter, compared to the consensus estimate of $201.11 million. Axon Enterprise had a negative return on []

Craig Hallum upgraded shares of Axon Enterprise (NASDAQ:AXON) from a hold rating to a buy rating in a report published on Tuesday morning, Analyst Ratings Network reports. Craig Hallum currently has $232.00 target price on the biotechnology companys stock. AXON has been the topic of a number of other research reports. Robert W. Baird boosted []

AXON earnings call for the period ending September 30, 2021.

The body-camera leader has a long runway for growth still ahead.

Stocks that traded heavily or had substantial price changes Tuesday:

Axon Enterprise Inc (NASDAQ:AXON) stock rose 7.80% (As on Nov 16, 11:04:09 AM UTC-4, Source: Google Finance) after the company in the third quarter of The post Axon Enterprise Inc (NASDAQ:AXON) delivers 39% year over year rise in the revenue appeared first on FXDailyReport.Com .